Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-21

Clinical Trial Update: Effect of RNS in Treatment-refractory Tourette's Syndrome [NA]

View source ↗

Summary

This clinical trial update notes that a study evaluating the effect of a responsive neurostimulation (RNS) device for treatment-refractory Tourette syndrome is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RNS System (responsive neurostimulation device)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Tourette Syndrome | NA | Status: RECRUITING